Voronoi, Inc. (310210) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Voronoi, Inc. (310210:KRX), powered by AI.
- Current Price
- ₩197,500
- P/E Ratio
- -85.1
- Market Cap
- 3.6T
- Sector
- Healthcare
What is the Voronoi, Inc. stock price forecast?
Voronoi, Inc. is currently trading at ₩197,500. View real-time AI analysis on Alpha Lenz.
What is Voronoi, Inc. insider trading activity?
View the latest insider trading data for Voronoi, Inc. on Alpha Lenz.
What is Voronoi, Inc.'s P/E ratio?
Voronoi, Inc.'s P/E ratio is -85.1.
Voronoi, Inc.
KRX · 310210“Voronoi, Inc. trades at a P/E of -85.1 (undervalued) with modest ROE of -50.2%.”
Ask for details →Company Overview
Voronoi, Inc. researches, develops, and discovers small molecule kinase inhibitors in South Korea. Its products pipeline includes VRN01, an oral leucine rich repeat kinase 2 inhibitor targeting glioblastoma multiforme to treat brain and pancreatic cancers; VRN07, VRN06, and VRN11 for the treatment of lung cancer; VRN08 and VRN10 to treat breast cancer; and VRN02 for the treatment of rheumatoid arthritis and atopic dermatitis. The company's products pipeline also comprise VRN04-1 to treat autoimmune diseases; VRN04-2 for the treatment of multiple sclerosis and amyotrophic lateral sclerosis; VRN13 to treat pulmonary arterial hypertension; and VRN14 for the treatment of refractory solid cancer. Voronoi, Inc. was founded in 2015 and is based in Incheon, South Korea.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Voronoi, Inc. trades at a P/E of -85.1 (undervalued) with modest ROE of -50.2%.”
Ask for details →Frequently Asked Questions
Voronoi, Inc. (ticker: 310210) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 139 employees. Market cap is $3.6T.
The current price is ₩197,500 with a P/E ratio of -85.1x and P/B of 35.02x.
ROE is -50.18% and operating margin is -723.94%. Annual revenue is $7.5B.